Nomura Holdings’s Puma Biotechnology PBYI Stock Holding History

Nomura Holdings’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-105,103	Closed	-$322K	–	2307
2021 Q4	$322K	Buy	+105,103	New	+$456K	﹤0.01%	1658
2021 Q1	–	Sell	-40,000	Closed	-$414K	–	2178
2020 Q4	$414K	Hold	40,000	–	–	﹤0.01%	1277
2020 Q3	$404K	Buy	+40,000	New	+$407K	﹤0.01%	1050
2020 Q1	–	Sell	-35,224	Closed	-$308K	–	1155
2019 Q4	$308K	Buy	+35,224	New	+$292K	﹤0.01%	971
2015 Q3	–	Sell	-17,883	Closed	-$2.06M	–	1875
2015 Q2	$2.06M	Buy	+17,883	New	+$3.24M	0.01%	805
2014 Q3	–	Sell	-5,000	Closed	-$333K	–	2978
2014 Q2	$333K	Buy	+5,000	New	+$356K	﹤0.01%	2051

Other funds holding PBYI

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Nomura Holdings's PBYI Position: Q1 2022 in Review

Nomura Holdings sold out of Puma Biotechnology (PBYI) in Q1 2022, closing a stake of 105,103 shares — an estimated $322K sold.

Nomura Holdings first reported a position in PBYI in Q2 2014 and held it in 6 quarters. The position peaked at $2.06M in Q2 2015. 104 funds tracked by Wall St. Rank hold PBYI as of Q1 2022.

Nomura Holdings reported no remaining Puma Biotechnology position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 105,103 Puma Biotechnology shares in Q1 2022, an estimated $322K.
Nomura Holdings first reported a position in Puma Biotechnology in Q2 2014 and held it in 6 quarters.
Nomura Holdings's Puma Biotechnology position peaked at $2.06M in Q2 2015.
104 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.